Tollenaar RAEM - Search Results

1

The effects of tumor resection and adjuvant therapy on the peripheral blood immune cell profile in patients with colon carcinoma.

Krijgsman D, De Vries NL, Andersen MN, Skovbo A, Tollenaar RAEM, Bastiaannet E, Kuppen PJK, Hokland M. Krijgsman D, et al. Among authors: tollenaar raem. Cancer Immunol Immunother. 2020 Oct;69(10):2009-2020. doi: 10.1007/s00262-020-02590-z. Epub 2020 May 12. Cancer Immunol Immunother. 2020. PMID: 32399587 Free PMC article.

2

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

Kuppen PJ, Jonges LE, van de Velde CJ, Vahrmeijer AL, Tollenaar RA, Borel Rinkes IH, Eggermont AM. Kuppen PJ, et al. Br J Cancer. 1997;75(10):1497-500. doi: 10.1038/bjc.1997.255. Br J Cancer. 1997. PMID: 9166943 Free PMC article.

3

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.

Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ. Vahrmeijer AL, et al. Br J Cancer. 2000 May;82(9):1539-46. doi: 10.1054/bjoc.2000.1175. Br J Cancer. 2000. PMID: 10789721 Free PMC article. Clinical Trial.

4

Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer.

van der Burg SH, de Cock K, Menon AG, Franken KL, Palmen M, Redeker A, Drijfhout J, Kuppen PJ, van de Velde C, Erdile L, Tollenaar RA, Melief CJ, Offringa R. van der Burg SH, et al. Eur J Immunol. 2001 Jan;31(1):146-55. doi: 10.1002/1521-4141(200101)31:1<146::aid-immu146>3.0.co;2-t. Eur J Immunol. 2001. PMID: 11169448 Free article.

5

Caspase-3 activity as a prognostic factor in colorectal carcinoma.

Jonges LE, Nagelkerke JF, Ensink NG, van der Velde EA, Tollenaar RA, Fleuren GJ, van de Velde CJ, Morreau H, Kuppen PJ. Jonges LE, et al. Lab Invest. 2001 May;81(5):681-8. doi: 10.1038/labinvest.3780277. Lab Invest. 2001. PMID: 11351040 Free article.

6

Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine.

van der Burg SH, Menon AG, Redeker A, Bonnet MC, Drijfhout JW, Tollenaar RA, van de Velde CJ, Moingeon P, Kuppen PJ, Offringa R, Melief CJ. van der Burg SH, et al. Clin Cancer Res. 2002 May;8(5):1019-27. Clin Cancer Res. 2002. PMID: 12006514 Clinical Trial.

7

Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients.

Menon AG, Morreau H, Tollenaar RA, Alphenaar E, Van Puijenbroek M, Putter H, Janssen-Van Rhijn CM, Van De Velde CJ, Fleuren GJ, Kuppen PJ. Menon AG, et al. Lab Invest. 2002 Dec;82(12):1725-33. doi: 10.1097/01.lab.0000043124.75633.ed. Lab Invest. 2002. PMID: 12480922 Free article.

8

A basal membrane-like structure surrounding tumour nodules may prevent intraepithelial leucocyte infiltration in colorectal cancer.

Menon AG, Fleuren GJ, Alphenaar EA, Jonges LE, Janssen van Rhijn CM, Ensink NG, Putter H, Tollenaar RA, van de Velde CJ, Kuppen PJ. Menon AG, et al. Cancer Immunol Immunother. 2003 Feb;52(2):121-6. doi: 10.1007/s00262-002-0363-6. Epub 2003 Jan 30. Cancer Immunol Immunother. 2003. PMID: 12594576 Free PMC article.

9

Safety of intravenous administration of a canarypox virus encoding the human wild-type p53 gene in colorectal cancer patients.

Menon AG, Kuppen PJ, van der Burg SH, Offringa R, Bonnet MC, Harinck BI, Tollenaar RA, Redeker A, Putter H, Moingeon P, Morreau H, Melief CJ, van de Velde CJ. Menon AG, et al. Cancer Gene Ther. 2003 Jul;10(7):509-17. doi: 10.1038/sj.cgt.7700600. Cancer Gene Ther. 2003. PMID: 12833131

10

Magnitude and polarization of P53-specific T-helper immunity in connection to leukocyte infiltration of colorectal tumors.

van der Burg SH, Menon AG, Redeker A, Franken KL, Drijfhout JW, Tollenaar RA, Hartgrink HH, van de Velde CJ, Kuppen PJ, Melief CJ, Offringa R. van der Burg SH, et al. Int J Cancer. 2003 Nov 10;107(3):425-33. doi: 10.1002/ijc.11419. Int J Cancer. 2003. PMID: 14506743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

462 results

Search Page